[1] Chalasani N, Younossi Z, Lavine J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 2018, 67:328-357.
[2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病防治指南(2018年更新版). 实用肝脏病杂志. 2018,21:170-176.
[3] Cassinotto C, Boursier J, De LV, et al. Liver stiffness in nonalcoholic fatty liver disease: A comparison of Supersonic Shear Imaging, FibroScan and ARFI with liver biopsy. Hepatology. 2016,63:1817-1827.
[4] 曾静, 范建高. 弹性成像技术在慢性肝病诊断中应用的美国共识. 实用肝脏病杂志, 2018, 21:32-33.
[5] Chen J, Yin M, Talwalkar JA, et al. Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. Radiology. 2017,283:418-428.
[6] Loomba R, Cui J, Wolfson T, et al. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Am J Gastroenterol,2016,111:986-994.
[7] Alkhouri N, Berk M, Yerian L, et al. OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology,2014,59:1617-1624.
[8] Siddiqui MS, Patidar KR, Boyett S, et al. Performance of Non-invasive Models of Fibrosis in Predicting Mild to Moderate Fibrosis in Patients with Nonalcoholic Fatty Liver Disease (NAFLD). Liver Int,2016, 36:572-579.
[9] Mcpherson S, Hardy T, Dufour JF, et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. Am J Gastroenterol,2017,112:740-751.
[10] Liu XL, Pan Q, Zhang RN, et al. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World J Gastroenterol,2016, 22: 9844-9852.
[11] Younossi ZM, Loomba R, Anstee QM, et al. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology,2018,68:349-360. |
